CJC-1295 With DAC 5mg: A Complete Research Overview

CJC-1295 with DAC 5mg is a five-milligram research vial of a long-acting growth hormone-releasing hormone (GHRH) analog. The Drug Affinity Complex, or DAC, lets the peptide bind to serum albumin, which slows clearance and extends its activity window in laboratory models to roughly six to eight days. It is sold for research use only and is not FDA-approved for human use in the United States.

What CJC-1295 With DAC 5mg Actually Is

CJC-1295 is a synthetic analog of growth hormone-releasing hormone. Four amino acid substitutions make the molecule resistant to DPP-IV, the enzyme that rapidly degrades natural GHRH. The DAC portion adds a maleimide linker that forms a covalent bond with albumin in the bloodstream.

That albumin bond is the entire point of the design. Unmodified GHRH disappears from circulation within minutes, while the albumin-bound version stays available for days. Researchers often shorten the full product name to cjc 1295 dac 5mg when they compare catalog listings or plan a study.

The 5mg figure refers to the amount of lyophilized powder in the vial, not to a dose. Vial size is a packaging detail, and it says nothing about how much peptide should be used in an experiment.

With DAC vs Without DAC: Key Differences

Two versions of CJC-1295 circulate in the research market, and they behave very differently. The DAC-free version is usually sold as mod GRF 1-29 or CJC-1295 without DAC. Blending the two names is a common source of confusion.

Feature	CJC-1295 with DAC	CJC-1295 without DAC
Albumin binding	Yes, covalent	No
Reported half-life	About 6 to 8 days	About 30 minutes
Administration frequency in animal models	Once weekly or less	Several times per day
Effect on GH release pattern	Raises baseline, flattens pulses	Preserves pulsatile release
Common catalog sizes	2mg, 5mg	2mg, 5mg, 10mg

The two forms are not interchangeable in a research protocol. A long-acting analog produces a sustained elevation in baseline growth hormone, while the short-acting form is used when a study needs to preserve natural pulse frequency.

Reconstitution and Storage Basics

Lyophilized peptide is normally reconstituted with bacteriostatic water or another sterile diluent. Add the liquid slowly down the inside wall of the vial, then swirl gently until the powder dissolves. Shaking introduces bubbles and can shear the peptide chain.

Exact cjc-1295 dac 5mg mixing instructions differ from one supplier to the next, so the certificate of analysis that ships with the vial is the best starting point. Reconstituted solutions are typically stored at 2 to 8 degrees Celsius, protected from light, and used within the window the manufacturer specifies.

Repeated freeze-thaw cycles are widely avoided because they can cause aggregation and reduce the accuracy of downstream measurements. Sterile technique protects both the sample and the person handling it, even in a non-clinical setting.

CJC-1295 With DAC vs Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that acts on the ghrelin receptor, while CJC-1295 acts on the GHRH receptor. They trigger different signaling pathways, which is why a direct cjc-1295 with dac vs ipamorelin comparison focuses on mechanism and timing rather than on which compound is better.

Attribute	CJC-1295 with DAC	Ipamorelin
Receptor target	GHRH receptor	Ghrelin / GHS-R1a receptor
Reported half-life	About 6 to 8 days	About 2 hours
GH pulse pattern	Elevated baseline, reduced amplitude	Preserves pulse frequency
Typical research role	Long-acting GHRH signal	Short-acting secretagogue signal

Stacking the Two in Research

Animal studies suggest that activating both receptors can produce a larger growth hormone response than either compound alone. That is why the pair appears together in so much preclinical work. The central design question is cjc-1295 ipamorelin with dac or without, because the DAC group determines how often the peptide has to be given.

Vendors also sell pre-blended vials that combine both peptides in one container. Pre-mixed products remove one reconstitution step but lock the ratio in place. Research groups that need to adjust the ratio usually purchase the peptides separately.

Dosing Questions and Community Claims

Online forums contain plenty of self-reported schedules, and searches for cjc 1295 with dac dosage reddit return threads that mention 1mg to 2mg per week. Those figures trace back to early industry research, not to controlled human trials with published safety endpoints. No regulatory agency has established a safe or effective human dose of CJC-1295 with DAC.

People also ask how long a single 5mg vial lasts, whether administration should happen at night, and whether fasting changes the response. None of those questions has a validated human answer for this peptide. A forum post is not a substitute for clinical guidance.

Safety, Legal Status, and Next Steps

CJC-1295 with DAC is not FDA-approved for human use, and it is not a dietary supplement. Products labeled for research use only are not held to the same purity, sterility, and labeling standards as prescription drugs. That gap matters when a compound is handled outside a controlled laboratory.

Anecdotal reports of side effects include injection-site irritation, flushing, and headache, but uncontrolled reports cannot establish cause and effect. Long-term human safety data for this peptide do not exist.

Anyone with questions about growth hormone, IGF-1, or pituitary function should speak with a licensed physician. Self-experimentation with unapproved research peptides carries unknown risks, including interactions with prescription medications that have never been studied.

COMMON QUESTIONS

Frequently Asked Questions

Is CJC-1295 with DAC 5mg approved for human use?

No. CJC-1295 with DAC is sold as a research chemical and is not FDA-approved for human use in the United States. It is not a dietary supplement, and products labeled for research use are not held to prescription-drug purity or sterility standards.

How long does CJC-1295 with DAC stay active?

The DAC group extends the peptide's reported half-life to roughly six to eight days by binding it to serum albumin. The DAC-free version, often called mod GRF 1-29, has a reported half-life of about 30 minutes. Human pharmacokinetic data remain limited.

Does CJC-1295 with DAC need to be stacked with ipamorelin?

No research protocol requires the combination, but preclinical studies often pair a GHRH analog with a ghrelin-receptor agonist like ipamorelin to test whether the two pathways act additively. There is no validated human dosing schedule for either peptide, alone or combined. Anyone considering human use should consult a licensed healthcare professional.